The goal of the NBCI Interactive Clinical Trials Portal is to improve the health outcomes of the African American community by making African Americans aware of the critical features, benefits, and challenges of clinical trials. This study website provides scientific facts that may positively influence African Americans' feelings about their participation in clinical trials. Additionally, this website attempts to provide an understanding of the complex relationship African Americans have historically had with clinical trials.
The National Black Church Initiative (NBCI) is a coalition of 150,000 African-American and Latino churches with a population of 27.7 million covering all therapeutic demographic groups working to eradicate racial disparities in healthcare, clinical trials, technology, education, housing, and the environment.
US regulatory agency makes ‘big change’ to increase the number of participants from under-represented groups in drug testing.
The US Food and Drug Administration (FDA) will soon require researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants.
A wave of new therapies is starting to reshape the treatment landscape for people with rare anemias, but the authors of a new review also caution that more research is needed to better understand which therapies are right for which patients.